Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Influenza
Interventions
BIOLOGICAL

Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

seasonal influenza vaccine 15ug

Trial Locations (3)

53100

Presidio Distrettuale No. 8 Azienda Sanitaria USL 7 di Siena, Siena

Unknown

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via Dei Vestini

Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto sede legale, Via S. Spaventa, 37, Lanciano

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY